PTC Therapeutics Inc.

PTC Therapeutics Inc.

World Rank (Aug-2026)
3206
Market Cap (Aug-2026)
5.984 Billion USD
World Rank (Jan-05-2024)
5,486
Market Cap (Jan-05-2024)
2.120 Billion USD
World Rank (Jul-30-2023)
4,320
Market Cap (Jul-30-2023)
3.037 Billion USD
World Rank (Jan-07-2022)
5,237
Market Cap (Jan-07-2022)
2.694 Billion USD
World Rank (Jan-01-2021)
3,400
Market Cap (Jan-01-2021)
4.164 Billion USD
Headquarters Country
USA
Top Healthcare Companies in USA
Nasdaq / NYSE Code
PTCT
Employee Count
1,177
Employee Count as of Date
As on 2021
Headquarters City/State
New Jersey
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
1,731 Million USD
Annual Operating Income in USD
867 Million USD
Annual Net Income in USD
683 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
2,899 Million USD
Total Liabilities in USD
3,104 Million USD
Total Equity in USD
-205 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
HealthCare Products
Biotechnology
Biopharmaceutical
Company Website
PTC THERAPEUTICS INC
Yahoo
Yahoo @ Nasdaq
Company Profile

PTC Therapeutics is a Commercial and Diversified Biopharmaceutical company. It operates offices and research labs in more than 20 countries and occupy a business footprint in more than 50 countries around the world. It is a having 2,20,000 square feet in Hopewell, New Jersey. The headquarters is in USA.

Annual Results Summary

PTC THERAPEUTICS - Yearly Revenue and Net Income - in Million USD:

Year - EndingRevenueOperating IncomeNet Income
Dec-2022698-439 (Loss)-559 (Loss)
Dec-2021538-374 (Loss)-523 (Loss)
Dec-2020380-397 (Loss)-438 (Loss)
Balance Sheet Summary

Total Assets as on Dec-2022 was 1,705 Million USD.

Total Liabilities as on Dec-2022 was 2,052 Million USD.

Total Equity as on Dec-2022 was -347 Million USD.

Founded Year
1998
IPO Year
2013
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share